A Phase I Trial on the Relative Bioavailability and Food Effect of HRS-1893 Tablets in Healthy Subjects (clinicaltrials.gov) - Dec 10, 2025 - P1 | N=38 | Not yet recruiting | Sponsor: Shandong Suncadia Medicine Co., Ltd.
New P1 trial • Cardiomyopathy • Cardiovascular
|